Skip to content
healthcare.dev

Carbamazepine

NDC 17856-4047, Carbamazepine, suspension, from Atlantic Biologicals Corps.

Product NDC
17856-4047
Status
Listed
Labeler
Atlantic Biologicals Corps
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076729
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/17856-4047 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBAMAZEPINE100 mg/5mL

Pharmacologic classes

Cytochrome P450 1A2 Inducers [MoA]; Cytochrome P450 2B6 Inducers [MoA]; Cytochrome P450 2C19 Inducers [MoA]; Cytochrome P450 2C9 Inducers [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]; Mood Stabilizer [EPC]

Package NDCNDC-11Package
17856-4047-11785640470110 mL in 1 CUP (17856-4047-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/25939406-a836-43cd-9301-56808e9b31ec

Use it

Look up 17856-4047 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/17856-4047 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 17856-4047. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.